Cargando…
Clinical Translationality of KCNJ5 Mutation in Aldosterone Producing Adenoma
Hypertension due to primary aldosteronism poses a risk of severe cardiovascular complications compared to essential hypertension. The discovery of the KCNJ5 somatic mutation in aldosteroene producing adenoma (APA) in 2011 and the development of specific CYP11B2 antibodies in 2012 have greatly advanc...
Autores principales: | Kitamoto, Takumi, Nishikawa, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409469/ https://www.ncbi.nlm.nih.gov/pubmed/36012306 http://dx.doi.org/10.3390/ijms23169042 |
Ejemplares similares
-
Recurrence of Primary Aldosteronism After Surgery in Aldosterone-producing Adenoma With KCNJ5 Gene Mutation
por: Aiga, Ko, et al.
Publicado: (2023) -
Prevalence of Somatic KCNJ5 Mutations in Thai Patients With Aldosterone-Producing Adrenal Adenomas
por: Warachit, Wasita, et al.
Publicado: (2018) -
A Novel Case of Somatic KCNJ5 Mutation in Pediatric-Onset Aldosterone-Producing Adenoma
por: Uchida, Noboru, et al.
Publicado: (2017) -
SAT-555 Can Histology Predict the Presence of KCNJ5 Somatic Mutation in Aldosterone-Producing Adenomas?
por: Yamazaki, Yuto, et al.
Publicado: (2020) -
KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater Recovery of Arterial Stiffness
por: Chang, Yi-Yao, et al.
Publicado: (2021)